Search - tctmd.com

Displaying 561 - 580 of 2272

Sort: Relevancy | Date

Presentation TCT 2020

TCT 602: Bewildering Pseudoaneurysm: An Odyssey of Cover Stenting

Presenter: ROOPESH SINGHAL

October 14, 2020

Presentation TCT 2020

TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation

Presenter: Matthias Lutz

October 14, 2020

Presentation TCT 2020

TCT 625: Stent Positioning Device Usage During PCI of Left Main Bifurcation

Presenter: Dmitrii Monosov

October 14, 2020

Presentation TCT 2020

TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR)

Presenter: Jason Nogic

October 14, 2020

Presentation TCT 2020

TCT 391: 10-Year Outcomes After Drug-Eluting Stent Placement in Women Versus Men

Presenter: Nicole Pristera

October 14, 2020

Presentation TCT 2020

TCT 389: Risk of Major Bleeding in the 10 Years after DES in an All-Comers Population

Presenter: Calvin Sheng

October 14, 2020

Presentation TCT 2020

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

Presenter: Robert Yeh

October 14, 2020

Presentation TCT 2020

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

Presenter: Luca Testa

October 14, 2020

Presentation TCT 2020

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

Presenter: Wojciech Wanha

October 14, 2020

Presentation TCT 2020

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Presenter: Alexandre Abizaid

October 14, 2020

Presentation TCT 2020

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

Presenter: A D S P K Athukorala

October 14, 2020

Presentation TCT 2020

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

Presenter: Markus Krackhardt

October 14, 2020

Presentation TCT 2020

TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study

Presenter: Dimitri Karmpaliotis

October 14, 2020

Presentation TCT 2020

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

Presenter: Adrian Wlodarczak

October 14, 2020

Presentation TCT 2020

TCT 263: A Novel Risk Score to Predict One-year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP PCI)

Presenter: Sorin Brener

October 14, 2020

Presentation TCT 2020

TCT 256: Computational Modelling to Assess Efficacy of Drug Coated Balloon Therapy

Presenter: Karthic Anbalakan

October 14, 2020

Presentation TCT 2020

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

Presenter: Bernhard Witzenbichler

October 14, 2020

Presentation TCT 2020

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

Presenter: Lorenz Raber

October 14, 2020

Presentation TCT 2020

TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial

Presenter: Takeshi Nishi

October 14, 2020

Presentation TCT 2020

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

Presenter: Bernardo Cortese

October 14, 2020

Advertisement

TCT 602: Bewildering Pseudoaneurysm: An Odyssey of Cover Stenting

TCT 529: 12-y/o Female Patient Treated With a Second-Generation Tyrocore Sirolimus-Eluting Bioresorbable Scaffold in a Denovo Coronary Stenosis in the Donor Heart After Transplantation

TCT 625: Stent Positioning Device Usage During PCI of Left Main Bifurcation

TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR)

TCT 391: 10-Year Outcomes After Drug-Eluting Stent Placement in Women Versus Men

TCT 389: Risk of Major Bleeding in the 10 Years after DES in an All-Comers Population

TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study

TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population

TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry)

TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry

TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease

TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study

TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry

TCT 263: A Novel Risk Score to Predict One-year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP PCI)

TCT 256: Computational Modelling to Assess Efficacy of Drug Coated Balloon Therapy

TCT 260: A Prospective Randomized Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus Eluting Stent in the Treatment of Subjects With up to Two De Novo Coronary Artery Lesions – BIOFLOW IV: 5 Year Clinical Results

TCT 267: BIOVITESSE – Multicenter Prospective First-In-Man Study of a New Polymer Free Drug-coated Stent With Ultrathin Struts: Clinical Study Outcome

TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial

TCT 255: Long Term Outcome After Coronary Revascularization With Sirolimus Coated Balloon in Patients With Small Vessel Disease (≤2.75mm): 3-Years Results From Nanolute Real-World Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content